1921
Volume 95, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

Early childhood enteric infections have adverse impacts on child growth and can inhibit normal mucosal responses to oral vaccines, two critical components of environmental enteropathy. To evaluate the role of indoleamine 2,3-dioxygenase 1 (IDO1) activity and its relationship with these outcomes, we measured tryptophan and the kynurenine–tryptophan ratio (KTR) in two longitudinal birth cohorts with a high prevalence of stunting. Children in rural Peru and Tanzania ( = 494) contributed 1,251 plasma samples at 3, 7, 15, and 24 months of age and monthly anthropometrics from 0 to 36 months of age. Tryptophan concentrations were directly associated with linear growth from 1 to 8 months after biomarker assessment. A 1-SD increase in tryptophan concentration was associated with a gain in length-for-age Z-score (LAZ) of 0.17 over the next 6 months in Peru (95% confidence interval [CI] = 0.11–0.23, < 0.001) and a gain in LAZ of 0.13 Z-scores in Tanzania (95% CI = 0.03–0.22, = 0.009). Vaccine responsiveness data were available for Peru only. An increase in kynurenine by 1 μM was associated with a 1.63 (95% CI = 1.13–2.34) increase in the odds of failure to poliovirus type 1, but there was no association with tetanus vaccine response. A KTR of 52 was 76% sensitive and 50% specific in predicting failure of response to serotype 1 of the oral polio vaccine. KTR was associated with systemic markers of inflammation, but also interleukin-10, supporting the association between IDO1 activity and immunotolerance. These results strongly suggest that the activity of IDO1 is implicated in the pathophysiology of environmental enteropathy, and demonstrates the utility of tryptophan and kynurenine as biomarkers for this syndrome, particularly in identifying those at risk for hyporesponsivity to oral vaccines.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.16-0037
2016-10-05
2017-09-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/95/4/928.html?itemId=/content/journals/10.4269/ajtmh.16-0037&mimeType=html&fmt=ahah

References

  1. Kosek M, Guerrant RL, Kang G, Bhutta Z, Penataro Yori P, Gratz J, Gottlieb M, Lang D, Lee G, Haque R, Mason C, Ahmed T, Lima AA, Petri WA, Houpt E, Paredes Olortegui M, Seidman J, Mduma E, Samie A, Babji S, the MAL-ED Network Investigators; , 2014. Assessment of environmental enteropathy in the MAL-ED cohort study: theoretical and analytical framework. Clin Infect Dis 59 (Suppl 4): S239S247.[Crossref]
  2. Naylor C, Lu M, Haque R, Mondal D, Buonomo E, Nayak U, Mychlaeckyj JC, Kirkpatrick B, Colgate R, Carmolli M, Dickson D, van der Klis F, Weldon W, Oberste MO, The PROVIDE study teams Ma JC, Petri WA, Jr; , , 2015. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine 2: 17591766.[Crossref]
  3. Kelly P, Menzies I, Crane R, Zulu I, Nickols C, Feakins R, Mwansa J, Mudenda V, Katubulushi M, Greenwald S, Farthing M, , 2004. Responses of small intestinal architecture and function over time to environmental factors in a tropical population. Am J Trop Med Hyg 70: 412419.
  4. Galpin L, Manary MJ, Fleming K, Ou CN, Ashorn P, Shulman RJ, , 2005. Effect of Lactobacillus GG on intestinal integrity in Malawian children at risk of tropical enteropathy. Am J Clin Nutr 82: 10401045.
  5. Humphrey JH, , 2009. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 374: 10321035.[Crossref]
  6. Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A, McCormick BJ, McGrath M, Olortegui MP, Samie A, Shakoor S, Mondal D, Lima IF, Hariraju D, Rayamajhi BB, Qureshi S, Kabir F, Yori PP, Mufamadi B, Amour C, Carreon JD, Richard SA, Lang D, Bessong P, Mduma E, Ahmed T, Lima AA, Mason CJ, Zaidi AK, Bhutta ZA, Kosek M, Guerrant RL, Gottlieb M, Miller M, Kang G, Houpt ER, MAL-ED Network Investigators; , 2015. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health 3: e564e575.[Crossref]
  7. Schertzer JD, Steinberg GR, , 2014. Immunometabolism: the interface of immune and metabolic responses in disease. Immunol Cell Biol 92: 303.[Crossref]
  8. Munn DH, Mellor AL, , 2013. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol 34: 137143.[Crossref]
  9. Pena OM, Pistolic J, Raj D, Fjell CD, Hancock RE, , 2011. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol 186: 72437254.[Crossref]
  10. Beeson PB, , 1946. Development of tolerance to typhoid bacterial pathogen and its abolition by reticulo-endothelial cell blockade. Proc Soc Exp Biol Med 61: 248250.[Crossref]
  11. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW, , 1995. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85: 13411347.
  12. Richard SA, Barrett LJ, Guerrant RL, Checkley W, Miller MA, MAL-ED Network Investigators; , 2014. Disease surveillance methods used in the 8-site MAL-ED cohort study. Clin Infect Dis 59 (Suppl 4): S220S224.[Crossref]
  13. Yori PP, Lee G, Olortegui MP, Chávez CB, Flores JT, Vasquez AO, Burga R, Pinedo SR, Asayag CR, Black RE, Caulfield LE, Kosek M, , 2014. Santa Clara de Nanay: the MAL-ED cohort in Peru. Clin Infect Dis 59 (Suppl 4): S310S316.[Crossref]
  14. Mduma ER, Gratz J, Patil C, Matson K, Dakay M, Liu S, Pascal J, McQuillin L, Mighay E, Hinken E, Ernst A, Amour C, Mvungi R, Bayyo E, Zakaria Y, Kivuyo S, Houpt ER, Svensen E, , 2014. The etiology, risk factors, and interactions of enteric infections and malnutrition and the consequences for child health and development study (MAL-ED): description of the Tanzanian site. Clin Infect Dis 59 (Suppl 4): S325S330.[Crossref]
  15. WHO Multicentre Growth Reference Study Group, 2006. WHO child growth standards based on length/height, weight and age. Acta Paediatr Suppl 450: 7685.
  16. Barboza MS, Jr Silva TM, Guerrant RL, Lima AA, , 1999. Measurement of intestinal permeability using mannitol and lactulose in children with diarrheal diseases. Braz J Med Biol Res 32: 14991504.[Crossref]
  17. Lee GO, Kosek P, Lima AA, Singh R, Yori PP, Olortegui MP, Lamsam JL, Oliveira DB, Guerrant RL, Kosek M, , 2014. Lactulose: mannitol diagnostic test by HPLC and LC-MSMS platforms: considerations for field studies of intestinal barrier function and environmental enteropathy. J Pediatr Gastroenterol Nutr 59: 544550.[Crossref]
  18. Ramakrishnan A, Althoff KN, Lopez JA, Coles CL, Bream JH, , 2012. Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines. Cytokine 60: 661666.[Crossref]
  19. Rosales FJ, Topping JD, Smith JE, Shankar AH, Ross AC, , 2000. Relation of serum retinol to acute phase proteins and malarial morbidity in Papua New Guinea children. Am J Clin Nutr 71: 15821588.
  20. World Health Organization (WHO), 1997. Manual for the Virological Investigation of Poliomyelitis. Geneva, Switzerland: WHO.
  21. Borrow R, Balmer P, Roper MH, , 2007. The Immunological Basis of Immunization Series: Tetanus Update 2006. Geneva, Switzerland: World Health Organization.
  22. Robberstad B, Evjen-Olsen B, , 2010. Preventing mother to child transmission of HIV with highly active antiretroviral treatment in Tanzania: a prospective cost-effectiveness study. J Acquir Immune Defic Syndr 55: 397403.[Crossref]
  23. Walker SP, Chang SM, Powell CA, Grantham-McGregor SM, , 2005. Effects of early childhood psychosocial stimulation and nutritional supplementation on cognition and education in growth-stunted Jamaican children: prospective cohort study. Lancet 366: 18041807.[Crossref]
  24. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B, International Child Development Steering Group, , 2007. Developmental potential in the first 5 years for children in developing countries. Lancet 369: 6070.[Crossref]
  25. Glewwe P, Jacoby HG, King EM, , 2001. Early childhood nutrition and academic achievement: a longitudinal analysis. J Public Econ 81: 345368.[Crossref]
  26. Akachi Y, Canning D, , 2015. Inferring the economic standard of living and health from cohort height: evidence from modern populations in developing countries. Econ Hum Biol 19: 114128.[Crossref]
  27. Kosek M, Haque R, Lima A, Babji S, Shrestha S, Qureshi S, Amidou S, Mduma E, Lee G, Yori PP, Guerrant RL, Bhutta Z, Mason C, Kang G, Kabir M, Amour C, Bessong P, Turab A, Seidman J, Olortegui MP, Quetz J, Lang D, Gratz J, Miller M, Gottlieb M, MAL-ED Network Investigators; , 2013. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg 88: 390396.[Crossref]
  28. Gosselin K, McDonald C, Kellogg M, Manji K, Kisenge R, Aboud S, Maleta K, Benzoni N, Fawzi W, Manary M, Duggan C, , 2015. Serum citrulline does not predict stunting or environmental enteric dysfunction in Tanzanian and Malawian infants. FASEB J 29: 403.5.
  29. Wessells KR, Hess SY, Rouamba N, Ouédraogo ZP, Kellogg M, Goto R, Duggan C, Ouédraogo JB, Brown KH, , 2013. Associations between intestinal mucosal function and changes in plasma zinc concentration following zinc supplementation. J Pediatr Gastroenterol Nutr 57: 348355.[Crossref]
  30. Previsani N, Tangermann RH, Tallis G, Jafari HS, , 2015. World Health Organization guidelines for containment of poliovirus following type-specific polio eradication: worldwide, 2015. Morb Mortal Wkly Rep 64: 913917.[Crossref]
  31. Mellor AL, Munn DH, , 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762774.[Crossref]
  32. Dai X, Zhu BT, , 2010. Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions. J Histochem Cytochem 58: 1728.[Crossref]
  33. Gupta NK, Thaker AI, Kanuri N, Riehl TE, Rowley CW, Stenson WF, Ciorba MA, , 2012. Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. Inflamm Bowel Dis 18: 12141220.[Crossref]
  34. Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, Zecchi R, D'Angelo C, Massi-Benedetti C, Fallarino F, Carvalho A, Puccetti P, Romani L, , 2013. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39: 372385.[Crossref]
  35. Favre D, Mold J, Hunt PW, Kanwar B, Loke P, Seu L, Barbour JD, Lowe MM, Jayawardene A, Aweeka F, Huang Y, Douek DC, Brenchley JM, Martin JN, Hecht FM, Deeks SG, McCune JM, , 2010. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of Th17 to regulatory T cells in HIV disease. Sci Transl Med 2: 32ra36.[Crossref]
  36. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L, , 2006. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 4: 754759.[Crossref]
  37. Moehn S, Pencharz PB, Ball RO, , 2012. Lessons learned regarding symptoms of tryptophan deficiency and excess from animal requirement studies. J Nutr 142: 2231S2235S.[Crossref]
  38. Lepage N, McDonald N, Dallaire L, Lambert M, , 1997. Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clin Chem 43: 23972402.
  39. Nuss ET, Tanumihardjo SA, , 2011. Quality protein maize for Africa: closing the protein inadequacy gap in vulnerable populations. Adv Nutr 2: 217224.[Crossref]
  40. Vasal JK, , 2000. The quality protein maize story. Food Nutr Bull 21: 445450.[Crossref]
  41. Marcobal A, Kashyap PC, Nelson TA, Aronov PA, Donia MS, Spormann A, Fischbach MA, Sonnenburg JL, , 2013. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J 7: 19331943.[Crossref]
  42. Kampman-van de Hoek E, Jansmann AJM, van den Borne JJGC, van der Peet-Schwering CMC, van Beers-Schreurs H, Gerrits WJJ, , 2016. Dietary amino acid deficiency reduces the utilization of amino acids for growth in growing pigs after a period of poor health. J Nutr 146: 5158.[Crossref]
  43. Le Floc'h N, Matte JJ, Melchior D, van Milgen J, Seve B, , 2010. A moderate inflammation caused by the deterioration of housing conditions modifies Trp metabolism but not Trp requirement for growth of post-weaned piglets. Animal 4: 18911898.[Crossref]
  44. de Ridder K, Levesque CL, Htoo JK, de Lange CF, , 2012. Immune system stimulation reduces the efficiency of tryptophan utilization for body protein deposition in growing pigs. J Anim Sci 90: 34853491.[Crossref]
  45. Reeds PJ, Fjeld CR, Jahoor F, , 1994. Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states? J Nutr 124: 906910.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.16-0037
Loading
/content/journals/10.4269/ajtmh.16-0037
Loading

Data & Media loading...

  • Received : 13 Jan 2016
  • Accepted : 14 Jun 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error